Tradestie Institutional Equity Comparison Engine

ZLAB vs SLNO โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

SLNO Overall Edge

SLNO Captures Institutional Edge (3โ€“1 Pillars ยท 7โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Soleno Therapeutics, Inc. Common Stock (SLNO) driven by superior Valuation, Growth & Margin, Options & Structure while ZLAB counters with relative strength in Momentum & Technical. Fundamentally, ZLAB trades at N/M Forward P/E with -63.0% operating margin (-6.8% YoY revenue) versus SLNO at 8.4x Forward P/E and 33.6% operating margin (+0.0% YoY). In options structure, ZLAB sits in UNCLASSIFIED (58th %ile IV; Dealer Gamma Walls on Pro) against SLNO sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner SLNO
ZLAB N/M vs SLNO 8.4x Fwd P/E
Growth & Margin Winner SLNO
Op Margin -63.0% vs 33.6% ยท YoY -6.8% vs +0.0%
Momentum & Technical Winner ZLAB
1Y +9.7% vs -27.8% ยท 52W Pos 60% vs 39%
Options & Structure Winner SLNO
UNCLASSIFIED (58th %ile IV) vs UNCLASSIFIED (<1st %ile IV)
ZLAB NASDAQ
Zai Lab Limited American Depositary Shares
Pharmaceutical Preparations
$23.83
-3.13% 1D
Market Cap $3.0B
1M Return +2.76%
1Y Return +9.66%
Forward P/E N/M
Unified AI Score
47.4 / 100 HOLD
Tech 25.0 Fund 39.0 Flow 50.0 Mom 53.5
SLNO NASDAQ
Soleno Therapeutics, Inc. Common Stock
Electromedical & Electrotherapeutic Apparatus
$53.01
+0.04% 1D
Market Cap $2.8B
1M Return +0.84%
1Y Return -27.84%
Forward P/E 8.4x
Unified AI Score
44.5 / 100 HOLD
Tech 40.0 Fund 40.0 Flow 51.0 Mom 25.9

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ZLAB +9.66% SLNO -27.84% Spread: +17.2 pp (SLNO Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
ZLAB TTM Op. Margin: -63.0% SLNO TTM Op. Margin: 33.6%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ZLAB vs SLNO. Trailing 12-month operating profitability (ZLAB -63.0% vs SLNO 33.6%) and valuation multiples (ZLAB N/M vs SLNO 8.4x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ZLAB (3) vs SLNO (7)
Institutional Metric ZLAB SLNO Criterion Row Winner
Market Capitalization Scale $3.0B $2.8B Larger Scale ZLAB
Trailing P/E Ratio Valuation N/M 27.5x Lower Multiple SLNO
Forward P/E Ratio Valuation N/M 8.4x Lower Multiple SLNO
Revenue Growth (YoY) Growth -6.8% +0.0% Higher Growth SLNO
Operating Margin (TTM) Profitability -63.0% 33.6% Higher Margin SLNO
Net Profit Margin Profitability -44.9% 33.7% Higher Margin SLNO
Return on Equity (ROE) Capital Efficiency -30.0% 26.4% Higher ROE SLNO
52-Week Range Position Momentum 60% ($16โ€“$29) 39% ($29โ€“$90) Stronger Trend ZLAB
Beta / 30D Volatility Risk Regime 1.19ฮฒ ยท 78% Vol 1.00ฮฒ ยท 2% Vol Lower Realized Risk SLNO
Unified Institutional Score Composite Signal 47.4 / 100 (HOLD) 44.5 / 100 (HOLD) Higher Composite ZLAB

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ZLAB vs SLNO Buy Guide
ZLAB UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 58th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live ZLAB Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
SLNO UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile <1st %ile
IV Regime Compressed (<25th %ile)
Live SLNO Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ZLAB nor SLNO registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.